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Iron-catalyzed direct a-arylation of ethers with
azoles†
Arkaitz Correa,*a Be´la Fiserb and Enrique Go´mez-Bengoab
The direct a-arylation of cyclic and acyclic ethers with azoles has been
achieved, which features a novel iron-catalyzed cross-dehydrogenative
coupling (CDC) process. This practical oxidative method allowed
the eﬃcient C2-alkylation of a variety of (benzo)azoles constituting
straightforward access to heterocycles of utmost medicinal signifi-
cance and highlighting the convenient use of feedstock substrates
and iron catalysts. A preliminary mechanism supported by DFT
calculations is discussed as well.
Since the end of the last century sustainable development has
constituted a matter of genuine concern for our society and
scientific community. As a result, ‘‘green chemistry’’ represents
one of the key factors for scientists when designing new chemical
processes.1 In this respect, the use of ethers such as tetrahydro-
furan (THF) and related derivatives as important raw chemicals for
the construction of more complex molecules of pharmaceutical
interest has recently received a great deal of attention.2 Indeed,
direct functionalization of molecules containing C(sp3)–H bonds
stands out today as one of the most challenging and relevant
areas in modern organic chemistry offering numerous attractive
advantages such as the reduction of the reliance on existing
functional groups while improving atom economy and energy
efficiency.3 The last few years have witnessed a burgeoning of
cross-dehydrogenative couplings (CDCs) involving the use of
catalytic amounts of first-row transition metals.4 Based on their
low-price, ready availability, and environmentally friendly char-
acter, iron salts5 constitute potentially ideal catalysts which offer
attractive advantages in this particular area of expertise. Despite
the impressive achievements, the assembly of new C–C linkages
based upon iron-catalyzed C(sp3)–H functionalization events are
still rare in the literature.6
Azoles are prevalent key motifs in a myriad of biologically active
compounds, agrochemicals and organic functional materials such
as liquid crystals and fluorescent dyes.7 Accordingly, C–H function-
alization of azoles is an active area of research which provides
simple and rapid access to a plethora of valuable functionalized
heterocyclic cores. Whereas arylation, alkenylation, alkynylation
and amination processes of azole derivatives have been widely
explored,8 direct alkylation still represents a challenge.9 N-Tosyl-
hydrazones10 and carboxylic acids11 are among the most common
coupling partners to perform C2-alkylation reactions of azoles.
Nevertheless, the most straightforward and convenient approach
involves the use of non-functionalized ethers via the addition
of in situ generated a-oxyalkyl radical species to heteroarenes
generally referred to as the Minisci reaction.12 Such processes
are of prime importance within medicinal chemistry and have
been accomplished using both copper13a and photoredox iridium
catalysts13b and even under metal-free conditions.13c While these
are efficient and elegant procedures, they still suffer from certain
limitations such as the restricted use of (benzo)thiazoles (route a),
isoquinolines and pyridines (route c) or requiring harsh reaction
conditions like using 4.0 equiv. of the oxidant at high temperatures
(route b). In this context, we envisioned whether the use of
iron salts would facilitate the development of a complementary
and advantageous strategy for the C2-alkylation of azoles with a
relatively broad scope and operational simplicity. In fact, iron
complexes are known to react with alkyl peroxides to generate
organic radical species which can further act as powerful oxidizing
agents.14 Herein we describe a novel CDC of (benzo)azoles and
ethers featuring the efficient use of a combination of FeF2 and
organic peroxides as the oxidant (Scheme 1).
We initially selected the direct coupling of benzothiazole (1a)
and tetrahydrofuran (THF, 2a) as the model system to evaluate the
feasibility of our approach. We anticipated that the nature of the
metal source and the oxidant would have a profound impact on
reactivity and accordingly the eﬀect of such variables was system-
atically examined.15 To our delight, the target CDC event took
place in a remarkable 51% yield when utilizing a combination
of FeF2 and tert-butyl peroxybenzoate at 90 1C (Table 1, entry 6).
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Further screening of the oxidants clearly revealed that TBHP was
the best choice while other common oxidants were much less
eﬀective (Table 1, entries 1–8). It is worth noting that the process
was found to be compatible with the use of an aqueous solution of
TBHP, albeit the product was obtained in a comparatively low yield
(entry 8). Importantly, the catalytic activity was highly dependent
on the counteranion and the use of other fluoride salts seemed to
have a crucial effect on the reaction outcome. FeF3 was found to be
as efficient as FeF2 (entry 12), but other iron sources (entries 9–11)
as well as other fluoride metal salts (entries 13 and 14) provided
lower yields.15 Remarkably, the yield was dramatically improved
upon reducing the amount of THF and adding 1,2-dichloroethane
as the co-solvent. Under those conditions the amount of oxidant
could be significantly reduced to 1.0 equivalent and 3a was
obtained in 80% yield (entry 17). The performance of the process
under an air atmosphere was detrimental to the reaction, although
3a was obtained in 62% yield. The addition of other additives
or variation of the temperature were found to be ineffective in
improving the catalyst performance.15–16 Additionally, several control
experiments evidenced that both the iron catalyst and the peroxide
were critical for success (Table 1, entries 15 and 16).
Having identified the optimal reaction conditions, we next
focused on examining the preparative scope and generality of our
iron-catalyzed direct arylation event. As shown for 3a–f, moderate
to good yields were obtained when differently substituted benzo-
thiazoles were utilized. It is noteworthy that electron-deficient
derivatives provided lower yields since full conversion was not
achieved. Importantly, several functional groups were accommo-
dated such as esters (3c), amides (3d), halides (3b and 3e), and
ethers (3f). Strikingly, the strongly coordinating nitrogen motif in
3d did not interfere with the coupling, which reveals a low Lewis
acidity, if any, of our catalyst system. Of particular importance
is the compatibility with the presence of halides, which provides
additional functionalization opportunities via cross-coupling
techniques. Notably, the method was found applicable for the
preparation of non-benzofused thiazoles (3g–h) and benzimida-
zoles (3i), albeit the products were obtained in moderate yields.
When benzoxazole derivatives were subjected to the optimized
conditions, the desired products were not detected. Gratifyingly,
minor modifications on the reaction conditions such as replacing
the use of TBHP by tert-butyl peroxybenzoate allowed for the
efficient coupling of several benzoxazoles (3j–l).17 In these cases,
the less basic benzoate species are generated by homolytic cleavage
of the oxidant and hence the corresponding coupling product can
be satisfactorily obtained,18 a significant improvement compared
to the parent Cu-catalyzed process (Table 2).13a
Aside from THF, other related cyclic and acyclic ethers are
commonly used as solvents in chemical processes and are pre-
valent key structures in a wide range of valuable compounds.
Scheme 1 Direct a-arylation of cyclic and acyclic ethers with azoles.
Table 1 Optimization of reaction conditions for the iron-catalyzed CDC
of 1a with THFa,b
Entry Metal salt Oxidant 3ab (%)
1 FeF2 K2S2O8 0
2 FeF2 DDQ 0
3 FeF2 Cumene hydroperoxide 0
4 FeF2 Dicumyl peroxide 0
5 FeF2 tBuOOtBu Traces
6 FeF2 tBuOOBz 51
7 FeF2 TBHP 62
8 FeF2 TBHP aq 41
9 FeCl2 TBHP Traces
10 Fe(OAc)2 TBHP 43
11 Fe(acac)3 TBHP 38
12 FeF3 TBHP 61
13 CoF2 TBHP 47
14 CuF2 TBHP 29
15 None TBHP 9
16 FeF2 None 0
17 FeF2 TBHP 80
c,d (62)
18 FeF2 TBHP 60
c,e
a Reaction conditions: 1a (0.5 mmol), 2a (1.0 mL), metal salt (10 mol%),
oxidant (2.0 equiv.) at 90 1C for 24 h under argon. b Yield of the isolated
product after column chromatography. c TBHP (1.0 equiv.) using 2a
(0.5 mL) in 1,2-dichloroethane (0.5 mL). d Under air. e at 80 1C. TBHP =
tert-butyl hydroperoxide (5.0–6.0 M in decane); TBHP aq = 70 wt%
tBuOOH in H2O.
Table 2 Iron-catalyzed CDC of azoles 1a–l with THFa,b
a Reaction conditions: 1 (0.5 mmol), FeF2 (10 mol%), TBHP (1.0 equiv.,
5.0–6.0 M in decane) in a mixture 2a : DCE (1 : 1, 1.0 mL) at 90 1C for 24 h
under argon. b Yield of the isolated product after column chromato-
graphy, average of at least two independent runs. c TBHP (2.0 equiv.)
using 2a (1.0 mL). d tBuOOBz (2.0 equiv.) using 2a (1.0 mL).
Communication ChemComm
This journal is©The Royal Society of Chemistry 2015 Chem. Commun., 2015, 51, 13365--13368 | 13367
Of particular interest is 1,3-dioxolane given that its coupling would
provide a masked formyl derivative through a practical and
aldehyde-free synthetic protocol. Accordingly, we next explored
the scope of our iron-catalyzed heteroarylation process regarding
the ether coupling partner. As shown in Table 3, a wide variety of
diﬀerently substituted benzothiazoles and benzoxazoles smoothly
underwent the coupling with 1,3-dioxolane to aﬀord the corres-
ponding acetal derivatives in good yields (3m–s). Remarkably,
1,3-dioxolane reacted selectively at the C2 position versus the
less reactive C4 atom providing 3n and 3o as single isomers.
However, in most cases both isomers were detected with high
regioselectivity (up to 9 : 1); whereas the products 3m and 3p
bearing the benzothiazole core were easily separated by column
chromatography, the benzoxazole derivatives 3q–3swere isolated as
inseparable mixtures of both isomers (regioselectivity up to 85 :15
determined by 1H NMR spectroscopy). Interestingly, 1,4-dioxane
could also be utilized to furnish the corresponding coupling
products in moderate to good yields (3t–v). It is noteworthy
that the acyclic ether 1,2-dimethoxyethane also underwent the
target reaction at both methylene and methyl sites with good
combined yields and high regioselectivities (up to 8 : 2; 3w : 3w0
and 3x : 3x0). Unfortunately, other coupling partners such as
dibutyl ether and ethanol or less acidic heterocycles such
as 1,2,3-triazoles and indoles were found unreactive under
our optimized conditions.
Although the detailedmechanistic picture clearly requires further
studies, several control experiments as well as DFT studies15,19 were
performed to gain some insights into the reaction mechanism.
The CDC event was entirely suppressed upon addition of radical
scavengers such as BHT and 1,1-diphenylethylene; interestingly,
in the latter case the coupling product 4 was isolated instead,
in 10% yield.20 Besides, the addition of TEMPO results in very
low conversion of the azole and just traces of the product
were detected. These experimental pieces of evidence tentatively
support a radical pathway. Notably, subsequent competition
experiments with benzoxazole 1j utilizing an equimolecular
mixture of THF/THF-d8 showed a significant kinetic isotopic
eﬀect (kH/kD = 3.18), thus suggesting that the C(sp
3)–H bond
cleavage with concomitant formation of an a-oxyalkyl radical is
likely the rate-determining step (Scheme 2). In order to clarify
the role of the iron catalyst, Sc(OTf)3, Bi(OTf)3 and AlCl3 were
used instead and the coupling product 3a was obtained in much
lower yields; hence it is unlikely that FeF2 is acting as a simple
Lewis acid.15,21 Based on the above results, a plausible mecha-
nism supported by DFT studies is outlined in Scheme 3. Initially,
FeF2 facilitates the homolytic cleavage of the starting oxidant to
form the hydroxide and tert-butoxy radical species under heating
conditions.6b,22 Computational data confirm that the homolytic
cleavage of tBuOOH is a highly endergonic process, with an uphill
Gibbs Free energy of 5.1 kcal mol1 and the Fe catalyst helps
stabilize the arising radical species by the formation of a very stable
Fe(III) complex, which lies ca. 80 kcal mol1 lower in energy than
the starting reactants. Next, the C(sp3)–H adjacent to the oxygen
atom of THF can be abstracted by tert-butoxy radical species to
furnish I, with an activation energy of only 12.5 kcal mol1,23 and
further oxidized through a SET event to the corresponding oxonium
cation II by FeF2(OH), lying ca. 5 kcal mol
1 lower in energy than
the sum of the starting Fe(III) complex and radical species.24 Finally,
the hydroxide anion is basic enough to easily deprotonate the azole
1a, with a low activation energy of only 2.6 kcal mol1, which
eventually reacts with oxonium ion II through an extremely favor-
able process (DGR = 82.1 Kcal mol1).25 On balance then, we
assume that FeF2 plays a key redox role in assisting both the
heterolytic cleavage of the oxidant and the oxidation of the carbon
radical I to the oxonium ion II.
In summary, we have developed a novel catalytic approach to
the direct a-heteroarylation of cyclic and acyclic ethers with azoles.
This practical and environmentally friendly protocol highlights
the advantageous use of iron salts and cheap feedstock substrates
Table 3 Iron-catalyzed CDC of azoles with other ethersa,b
a Reaction conditions: 1 (0.5 mmol), FeF2 (10 mol%), TBHP (1.0 equiv.,
5.0–6.0 M in decane) in a mixture 2a : DCE (1 : 1, 1.0 mL) at 90 1C for
24 h under argon. b Yield of the isolated product after column chro-
matography, average of at least two independent runs. c Ratio of C2 vs.
C4 isomer. d TBHP (2.0 equiv.) using 2 (1.0 mL). e tBuOOBz (2.0 equiv.)
using 2 (1.0 mL).
Scheme 2 Control experiments.
Scheme 3 Proposed mechanism.
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while featuring a dual C–H bond oxidative cross-coupling.
Furthermore, the method was found to be applicable to the
assembly of a wide variety of functionalized heterocycles
of paramount medicinal importance and represents an attractive,
yet complementary, strategy for the C–H alkylation of azoles. We
anticipate that our experimental and computational studies could
lead to acquiring new knowledge in catalyst design, thus opening
up new vistas in iron-catalyzed C–H functionalization events.
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